{
    "title": "Award in paper acknowledgments",
    "create_time": 1758615408.344632,
    "update_time": 1758615416.932087,
    "mapping": {
        "client-created-root": {
            "id": "client-created-root",
            "message": null,
            "parent": null,
            "children": [
                "882ea877-d72b-4c9d-acf1-de1b38ad198e"
            ]
        },
        "882ea877-d72b-4c9d-acf1-de1b38ad198e": {
            "id": "882ea877-d72b-4c9d-acf1-de1b38ad198e",
            "message": {
                "id": "882ea877-d72b-4c9d-acf1-de1b38ad198e",
                "author": {
                    "role": "system",
                    "name": null,
                    "metadata": []
                },
                "create_time": null,
                "update_time": null,
                "content": {
                    "content_type": "text",
                    "parts": [
                        ""
                    ]
                },
                "status": "finished_successfully",
                "end_turn": true,
                "weight": 0,
                "metadata": {
                    "is_visually_hidden_from_conversation": true
                },
                "recipient": "all",
                "channel": null
            },
            "parent": "client-created-root",
            "children": [
                "41108e94-824e-44d9-8dfc-278500a764aa"
            ]
        },
        "41108e94-824e-44d9-8dfc-278500a764aa": {
            "id": "41108e94-824e-44d9-8dfc-278500a764aa",
            "message": {
                "id": "41108e94-824e-44d9-8dfc-278500a764aa",
                "author": {
                    "role": "user",
                    "name": null,
                    "metadata": []
                },
                "create_time": 1758615407.707,
                "update_time": null,
                "content": {
                    "content_type": "text",
                    "parts": [
                        "There is a certain drug that I am interested in that was described in a paper that was published online in 2019. There are four authors for this paper, and at the time of publication, the authors of this paper were all associated with some institutions in one country from North America but were associated with exactly three different departments within that country. This paper discussed a type of radionuclide therapy that was approved by the FDA, based on data from NETTER-1, after the year 2000. This drug involves an element that was discovered in the first decade of the 20th century, has a density less than lead, and has its name derived from the ancient name for the capital of a European city. In this paper, what is the name of the award that covers the funding for this paper in the acknowledgments section?"
                    ]
                },
                "status": "finished_successfully",
                "end_turn": null,
                "weight": 1,
                "metadata": {
                    "developer_mode_connector_ids": [],
                    "selected_sources": [],
                    "selected_github_repos": [],
                    "serialization_metadata": {
                        "custom_symbol_offsets": []
                    },
                    "request_id": "98389a1bc93dea37-FCO",
                    "message_source": null,
                    "timestamp_": "absolute"
                },
                "recipient": "all",
                "channel": null
            },
            "parent": "882ea877-d72b-4c9d-acf1-de1b38ad198e",
            "children": [
                "06aafa0a-8e7b-4681-b447-e1f64cd1a138"
            ]
        },
        "06aafa0a-8e7b-4681-b447-e1f64cd1a138": {
            "id": "06aafa0a-8e7b-4681-b447-e1f64cd1a138",
            "message": {
                "id": "06aafa0a-8e7b-4681-b447-e1f64cd1a138",
                "author": {
                    "role": "assistant",
                    "name": null,
                    "metadata": []
                },
                "create_time": 1758615408.2135856,
                "update_time": null,
                "content": {
                    "content_type": "model_editable_context",
                    "model_set_context": "",
                    "repository": null,
                    "repo_summary": null,
                    "structured_context": null
                },
                "status": "finished_successfully",
                "end_turn": null,
                "weight": 1,
                "metadata": {
                    "request_id": "98389a1bc93dea37-FCO",
                    "message_type": "next",
                    "model_slug": "gpt-5",
                    "default_model_slug": "gpt-5",
                    "parent_id": "41108e94-824e-44d9-8dfc-278500a764aa",
                    "timestamp_": "absolute",
                    "model_switcher_deny": []
                },
                "recipient": "all",
                "channel": null
            },
            "parent": "41108e94-824e-44d9-8dfc-278500a764aa",
            "children": [
                "9b6ca78d-c0ee-42dc-8fff-b2a6e62c54fc"
            ]
        },
        "9b6ca78d-c0ee-42dc-8fff-b2a6e62c54fc": {
            "id": "9b6ca78d-c0ee-42dc-8fff-b2a6e62c54fc",
            "message": {
                "id": "9b6ca78d-c0ee-42dc-8fff-b2a6e62c54fc",
                "author": {
                    "role": "assistant",
                    "name": null,
                    "metadata": []
                },
                "create_time": 1758615408.249178,
                "update_time": null,
                "content": {
                    "content_type": "code",
                    "language": "unknown",
                    "response_format_name": null,
                    "text": "\"There is a certain drug that I am interested in that was described in a paper that was published online in 2019. There are four authors for this paper, and at the time of publication, the authors of this paper were all associated with some institutions in one country from North America but were associated with exactly three different departments within that country. This paper discussed a type of radionuclide therapy that was approved by the FDA, based on data from NETTER-1, after the year 2000. This drug involves an element that was discovered in the first decade of the 20th century, has a density less than lead, and has its name derived from the ancient name for the capital of a European city. In this paper, what is the name of the award that covers the funding for this paper in the acknowledgments section?\""
                },
                "status": "finished_successfully",
                "end_turn": null,
                "weight": 1,
                "metadata": {
                    "is_complete": true,
                    "finish_details": {
                        "type": "stop"
                    },
                    "sonic_classification_result": {
                        "latency_ms": 0.08597096893936396,
                        "search_prob": 0.16727163964527755,
                        "complex_search_prob": 0.29394683174967884,
                        "force_search_threshold": 0,
                        "classifier_config_name": "sonic_classifier_3cls_ev3",
                        "search_complexity": "simple"
                    },
                    "citations": [],
                    "content_references": [],
                    "request_id": "98389a1bc93dea37-FCO",
                    "message_type": "next",
                    "model_slug": "gpt-5",
                    "default_model_slug": "gpt-5",
                    "parent_id": "06aafa0a-8e7b-4681-b447-e1f64cd1a138",
                    "timestamp_": "absolute",
                    "model_switcher_deny": []
                },
                "recipient": "web.search",
                "channel": null
            },
            "parent": "06aafa0a-8e7b-4681-b447-e1f64cd1a138",
            "children": [
                "524d8ad4-485e-4cc7-817e-da68efdd73c7"
            ]
        },
        "524d8ad4-485e-4cc7-817e-da68efdd73c7": {
            "id": "524d8ad4-485e-4cc7-817e-da68efdd73c7",
            "message": {
                "id": "524d8ad4-485e-4cc7-817e-da68efdd73c7",
                "author": {
                    "role": "tool",
                    "name": "web.run",
                    "metadata": {
                        "sonicberry_model_id": "current_sonicberry_paid",
                        "real_author": "tool:web",
                        "source": "sonic_tool"
                    }
                },
                "create_time": 1758615408.758237,
                "update_time": null,
                "content": {
                    "content_type": "text",
                    "parts": [
                        ""
                    ]
                },
                "status": "finished_successfully",
                "end_turn": false,
                "weight": 1,
                "metadata": {
                    "search_model_queries": {
                        "type": "search_model_queries",
                        "queries": [
                            "2019 paper four authors three departments radionuclide therapy approved by FDA NETTER-1 acknowledgments funding award"
                        ]
                    },
                    "search_turns_count": 1,
                    "search_source": "composer_auto",
                    "client_reported_search_source": "composer_auto",
                    "request_id": "98389a1bc93dea37-FCO",
                    "message_type": "next",
                    "model_slug": "gpt-5",
                    "default_model_slug": "gpt-5",
                    "parent_id": "9b6ca78d-c0ee-42dc-8fff-b2a6e62c54fc",
                    "timestamp_": "absolute"
                },
                "recipient": "all",
                "channel": null
            },
            "parent": "9b6ca78d-c0ee-42dc-8fff-b2a6e62c54fc",
            "children": [
                "b79d522f-89ba-4393-9e07-77858f8e001d"
            ]
        },
        "b79d522f-89ba-4393-9e07-77858f8e001d": {
            "id": "b79d522f-89ba-4393-9e07-77858f8e001d",
            "message": {
                "id": "b79d522f-89ba-4393-9e07-77858f8e001d",
                "author": {
                    "role": "tool",
                    "name": "web.run",
                    "metadata": {
                        "sonicberry_model_id": "current_sonicberry_paid",
                        "real_author": "tool:web",
                        "source": "sonic_tool"
                    }
                },
                "create_time": 1758615408.7463093,
                "update_time": null,
                "content": {
                    "content_type": "text",
                    "parts": [
                        ""
                    ]
                },
                "status": "finished_successfully",
                "end_turn": false,
                "weight": 1,
                "metadata": {
                    "search_result_groups": [
                        {
                            "type": "search_result_group",
                            "domain": "pmc.ncbi.nlm.nih.gov",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/",
                                    "title": "177Lu-DOTATATE for the treatment ...",
                                    "snippet": "by S Das · 2019 · Cited by 140 — The therapy approval was based on findings from the randomized international phase III NETTER-1 trial as well as outcome data from a large European registry.",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "pmc.ncbi.nlm.nih.gov"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11876735\/",
                                    "title": "Results from a Substudy of the Phase III NETTER-1 Trial",
                                    "snippet": "by L Bodei · 2025 · Cited by 6 — Herein, we describe a NETTER-1 substudy that evaluated dosimetry (normal organs, whole body, and scintigraphically selected tumors) in patients ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "pmc.ncbi.nlm.nih.gov"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "oncpracticemanagement.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/oncpracticemanagement.com\/special-issues\/2019-fourth-annual-oncology-guide-to-new-fda-approvals\/lutathera-lutetium-lu-177-dotatate-first-radioactive-drug-approved-for-gastroenteropancreatic-neuroendocrine-tumors",
                                    "title": "Lutathera (Lutetium Lu 177 Dotatate) First Radioactive ...",
                                    "snippet": "by LA Raedler · Cited by 2 — Lutathera is a radiolabeled somatostatin analog, the first radiopharmaceutical and peptide receptor radionuclide therapy (PRRT) approved for GEP-NETs.",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "oncpracticemanagement.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "www.frontiersin.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.frontiersin.org\/journals\/nuclear-medicine\/articles\/10.3389\/fnume.2025.1655419\/full",
                                    "title": "Targeted radionuclide therapy and diagnostic imaging of ...",
                                    "snippet": "by KN Haugh — The most recent FDA-approved radiopharmaceutical for NET imaging is [64Cu]Cu-DOTA-TATE (Detectnet), which was FDA-approved in 2020 (12). Several clinical trials ...",
                                    "ref_id": null,
                                    "pub_date": 1754524800,
                                    "attribution": "www.frontiersin.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "www.mdpi.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.mdpi.com\/1424-8247\/12\/3\/114",
                                    "title": "Lutathera®: The First FDA- and EMA-Approved ...",
                                    "snippet": "by U Hennrich · 2019 · Cited by 448 — As the first radiopharmaceutical for Peptide Receptor Radionuclide Therapy (PRRT), Lutathera® was approved by the EMA in 2017 and the FDA in 2018 for the ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.mdpi.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "www.nature.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.nature.com\/articles\/s41573-020-0073-9",
                                    "title": "Radiopharmaceutical therapy in cancer: clinical advances ...",
                                    "snippet": "by G Sgouros · 2020 · Cited by 912 — Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach to treating many types of cancer.",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.nature.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "www.cms.gov",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.cms.gov\/medicare-coverage-database\/view\/lcd.aspx?lcdid=37851&ver=13",
                                    "title": "Biomarker Testing for Neuroendocrine Tumors\/Neoplasms",
                                    "snippet": "This document is about biomarker testing for neuroendocrine tumors, but the real-time PCR test is not covered as it is not medically necessary.",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.cms.gov"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "www.fda.gov",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.fda.gov\/media\/164194\/download",
                                    "title": "FDA Food Code 2022: Full Document",
                                    "snippet": "The Food Code is a model for safeguarding public health and ensuring food is unadulterated and honestly presented when offered to the consumer. It represents ...",
                                    "ref_id": null,
                                    "pub_date": 1674087958,
                                    "attribution": "www.fda.gov"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "static.e-publishing.af.mil",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/static.e-publishing.af.mil\/production\/1\/saf_ig\/publication\/dafi90-302\/dafi90-302.pdf",
                                    "title": "dafi90-302.pdf - Air Force - AF.mil",
                                    "snippet": "Mar 15, 2023 — This instruction provides policy for inspections involving Air Force and Space Force organizations, processes, programs, and procedures. It ...",
                                    "ref_id": null,
                                    "pub_date": 1753473810,
                                    "attribution": "static.e-publishing.af.mil"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "cprit.texas.gov",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/cprit.texas.gov\/media\/3347\/oc_board_packet_05152024.pdf",
                                    "title": "Oversight Committee Meeting",
                                    "snippet": "May 15, 2024 — Ken Smith will provide an update on the Product Development Research Program and present the PIC's product development award recommendations.",
                                    "ref_id": null,
                                    "pub_date": 1715881958,
                                    "attribution": "cprit.texas.gov"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "arxiv.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/arxiv.org\/abs\/1901.01286",
                                    "title": "A novel approach to medical radioisotope production using inverse kinematics: a successful production test of the theranostic radionuclide 67Cu",
                                    "snippet": "",
                                    "ref_id": null,
                                    "pub_date": 1546629441,
                                    "attribution": "arxiv.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/arxiv.org\/abs\/1610.09246",
                                    "title": "Feasibility of the $β^-$ Radio-Guided Surgery with a Variety of Radio-Nuclides of Interest to Nuclear Medicine",
                                    "snippet": "",
                                    "ref_id": null,
                                    "pub_date": 1477666068,
                                    "attribution": "arxiv.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/arxiv.org\/abs\/1210.0638",
                                    "title": "Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy",
                                    "snippet": "",
                                    "ref_id": null,
                                    "pub_date": 1349147372,
                                    "attribution": "arxiv.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/arxiv.org\/abs\/1807.00499",
                                    "title": "Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans and Bayesian Inference",
                                    "snippet": "",
                                    "ref_id": null,
                                    "pub_date": 1530516817,
                                    "attribution": "arxiv.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "en.wikipedia.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/en.wikipedia.org\/wiki\/Lutetium_%28177Lu%29_oxodotreotide",
                                    "title": "Lutetium (177Lu) oxodotreotide",
                                    "snippet": "",
                                    "ref_id": null,
                                    "pub_date": 1748553841,
                                    "attribution": "en.wikipedia.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/en.wikipedia.org\/wiki\/Peptide_receptor_radionuclide_therapy",
                                    "title": "Peptide receptor radionuclide therapy",
                                    "snippet": "",
                                    "ref_id": null,
                                    "pub_date": 1757521943,
                                    "attribution": "en.wikipedia.org"
                                }
                            ]
                        }
                    ],
                    "debug_sonic_thread_id": "thread_68d25770c530832f9372e5538af23fa6",
                    "search_turns_count": 1,
                    "search_source": "composer_auto",
                    "client_reported_search_source": "composer_auto",
                    "request_id": "98389a1bc93dea37-FCO",
                    "message_type": "next",
                    "model_slug": "gpt-5",
                    "default_model_slug": "gpt-5",
                    "parent_id": "524d8ad4-485e-4cc7-817e-da68efdd73c7",
                    "timestamp_": "absolute"
                },
                "recipient": "all",
                "channel": null
            },
            "parent": "524d8ad4-485e-4cc7-817e-da68efdd73c7",
            "children": [
                "47f2cc20-159f-47f8-881d-91c5c11c8c2d"
            ]
        },
        "47f2cc20-159f-47f8-881d-91c5c11c8c2d": {
            "id": "47f2cc20-159f-47f8-881d-91c5c11c8c2d",
            "message": {
                "id": "47f2cc20-159f-47f8-881d-91c5c11c8c2d",
                "author": {
                    "role": "tool",
                    "name": "web.run",
                    "metadata": {
                        "sonicberry_model_id": "current_sonicberry_paid",
                        "real_author": "tool:web",
                        "source": "sonic_tool"
                    }
                },
                "create_time": 1758615411.7432556,
                "update_time": null,
                "content": {
                    "content_type": "text",
                    "parts": [
                        ""
                    ]
                },
                "status": "finished_successfully",
                "end_turn": false,
                "weight": 1,
                "metadata": {
                    "search_model_queries": {
                        "type": "search_model_queries",
                        "queries": [
                            "2019 paper S Das 2019 4 authors US institution 177Lu DOTATATE S Das acknowledgments",
                            "paper by US authors about Lutathera 2019 acknowledgments award funding"
                        ]
                    },
                    "search_turns_count": 2,
                    "search_source": "composer_auto",
                    "client_reported_search_source": "composer_auto",
                    "request_id": "98389a1bc93dea37-FCO",
                    "message_type": "next",
                    "model_slug": "gpt-5",
                    "default_model_slug": "gpt-5",
                    "parent_id": "b79d522f-89ba-4393-9e07-77858f8e001d",
                    "timestamp_": "absolute"
                },
                "recipient": "all",
                "channel": null
            },
            "parent": "b79d522f-89ba-4393-9e07-77858f8e001d",
            "children": [
                "03af69e9-b855-4e55-a869-250018f3e359"
            ]
        },
        "03af69e9-b855-4e55-a869-250018f3e359": {
            "id": "03af69e9-b855-4e55-a869-250018f3e359",
            "message": {
                "id": "03af69e9-b855-4e55-a869-250018f3e359",
                "author": {
                    "role": "tool",
                    "name": "web.run",
                    "metadata": {
                        "sonicberry_model_id": "current_sonicberry_paid",
                        "real_author": "tool:web",
                        "source": "sonic_tool"
                    }
                },
                "create_time": 1758615411.7366629,
                "update_time": null,
                "content": {
                    "content_type": "text",
                    "parts": [
                        ""
                    ]
                },
                "status": "finished_successfully",
                "end_turn": false,
                "weight": 1,
                "metadata": {
                    "search_result_groups": [
                        {
                            "type": "search_result_group",
                            "domain": "pmc.ncbi.nlm.nih.gov",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/",
                                    "title": "177Lu-DOTATATE for the treatment ...",
                                    "snippet": "by S Das · 2019 · Cited by 140 — 177 Lu-DOTATATE is a type of peptide receptor radionuclide therapy that garnered FDA approval in January 2018 for the treatment of somatostatin receptor- ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "pmc.ncbi.nlm.nih.gov"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11002837\/",
                                    "title": "Current clinical application of lutetium‑177 in solid tumors ...",
                                    "snippet": "by T Niu · 2024 · Cited by 9 — In March, 2022, the U.S. Food and Drug Administration (FDA) approved the administration of 177Lu-PSMA-617 for the treatment of adult patients with mCRPC, making ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "pmc.ncbi.nlm.nih.gov"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "www.mdpi.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.mdpi.com\/1424-8247\/12\/3\/114",
                                    "title": "Lutathera®: The First FDA- and EMA-Approved ...",
                                    "snippet": "by U Hennrich · 2019 · Cited by 448 — Lutathera was approved by the EMA in 2017 and the FDA in 2018 for the treatment of somatostatin receptor (SSTR) positive gastroenteropancreatic neuroendocrine ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.mdpi.com"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.mdpi.com\/2227-9059\/11\/4\/1024",
                                    "title": "Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Adults with ...",
                                    "snippet": "by M Hertelendi · 2023 · Cited by 6 — Background: We have performed a systematic review to evaluate the efficacy and safety of [177Lu]Lu-DOTA-TATE, a radioligand therapy, ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.mdpi.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "pubmed.ncbi.nlm.nih.gov",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/pubmed.ncbi.nlm.nih.gov\/31652074\/",
                                    "title": "177Lu-DOTATATE for the treatment of ...",
                                    "snippet": "by S Das · 2019 · Cited by 140 — 177 Lu-DOTATATE is a type of peptide receptor radionuclide therapy that garnered FDA approval in January 2018 for the treatment of somatostatin receptor- ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "pubmed.ncbi.nlm.nih.gov"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "jnm.snmjournals.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/jnm.snmjournals.org\/content\/66\/7\/1075",
                                    "title": "Cost-Effectiveness of [177Lu]Lu-DOTATATE for the Treatment ...",
                                    "snippet": "by A Holzgreve · 2025 · Cited by 1 — [ 177 Lu]Lu-DOTATATE is cost-effective as a first-line treatment for patients with grade 2 or 3, well-differentiated, advanced gastroenteropancreatic ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "jnm.snmjournals.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/jnm.snmjournals.org\/content\/65\/5\/746",
                                    "title": "Effectiveness and Safety of Retreatment with 177 Lu ...",
                                    "snippet": "by ES Delpassand · 2024 · Cited by 3 — Retreatment with 177 Lu-DOTATATE after progression appeared to be well tolerated and offered disease control in patients with progressive NETs after initial ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "jnm.snmjournals.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/jnm.snmjournals.org\/content\/61\/7\/939",
                                    "title": "Unacceptable Denials | Journal of Nuclear Medicine",
                                    "snippet": "by J Czernin · 2020 · Cited by 1 — It also fails to acknowledge Centers for Medicare and Medicaid Services coverage of Lutathera. The denial letter indicates that Health Net ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "jnm.snmjournals.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/jnm.snmjournals.org\/content\/66\/3\/449",
                                    "title": "Dosimetry of [177Lu]Lu-DOTATATE in Patients with Advanced ...",
                                    "snippet": "by L Bodei · 2025 · Cited by 7 — ACKNOWLEDGMENTS. Under the direction of the authors, Jo Chapman, PhD, from Aspire Scientific Ltd., Bollington, U.K., provided medical writing ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "jnm.snmjournals.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "aacrjournals.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/aacrjournals.org\/clincancerres\/article\/25\/23\/6939\/82129\/Phase-I-Trial-of-Well-Differentiated",
                                    "title": "Phase I Trial of Well-Differentiated Neuroendocrine Tumors ...",
                                    "snippet": "We performed a phase I study to evaluate the safety and efficacy of SSTR2 antagonist 177 Lu-satoreotide tetraxetan.",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "aacrjournals.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/aacrjournals.org\/mct\/article\/22\/9\/1052\/728674\/Upregulation-of-Somatostatin-Receptor-Type-2",
                                    "title": "Upregulation of Somatostatin Receptor Type 2 Improves 177 ...",
                                    "snippet": "Our studies demonstrate significantly higher tumor uptake of SSTR2-targeted 177 Lu-DOTATATE in animals pretreated with HDACis compared with controls.",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "aacrjournals.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/aacrjournals.org\/mct\/article\/18\/5\/1012\/274167\/Preclinical-Investigation-of-212Pb-DOTAMTATE-for",
                                    "title": "Preclinical Investigation of 212 Pb-DOTAMTATE for Peptide ...",
                                    "snippet": "Our study describes the use of 212 Pb-DOTAMTATE, the octreotate analogue, in combination with 212 Pb, the parent of an alpha emitter.",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "aacrjournals.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "www.sciencedirect.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2949819825000159",
                                    "title": "The South Australian 177Lu-DOTATATE peptide receptor ...",
                                    "snippet": "by LM Altus · 2025 — We report on 189 patients who received 177 Lu-DOTATATE at a single South Australian centre over 11 years. Median overall survival was 48.4 months.",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.sciencedirect.com"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0969805121000032",
                                    "title": "Direct labeling of a somatostatin receptor antagonist via ...",
                                    "snippet": "by J Wang · 2021 · Cited by 6 — Acknowledgments. This work was supported by a University of Missouri Research Council award [Hennkens, URC 12-056] for funding and by the Institution ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.sciencedirect.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "www.researchgate.net",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.researchgate.net\/publication\/336814696_177_Lu-DOTATATE_for_the_treatment_of_gastroenteropancreatic_neuroendocrine_tumors",
                                    "title": "(PDF) 177 Lu-DOTATATE for the treatment of ...",
                                    "snippet": "Oct 30, 2019 — Abstract and Figures ; 177. Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine. tumors ; Satya Das. a. , Taymeyah Al-Toubah ; b.",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.researchgate.net"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "ajronline.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/ajronline.org\/doi\/10.2214\/AJR.19.21123",
                                    "title": "Therapy With 177 Lu-DOTATATE: Clinical Implementation and ...",
                                    "snippet": "by AT Kendi · 2019 · Cited by 64 — The purpose of this article is to enhance knowledge of the clinical implementation of peptide receptor radionuclide therapy (PRRT) and its impact on care of ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "ajronline.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "link.springer.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/link.springer.com\/article\/10.1007\/s00259-022-05771-3",
                                    "title": "Efficacy and safety of 177 Lu‑DOTATATE in patients with ...",
                                    "snippet": "by D Clement · 2022 · Cited by 18 — Acknowledgements. The authors thank Ivan De Backer, PhD, and NexGen Healthcare Communications for medical writing support, funded by Advanced ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "link.springer.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "dhpp.hpfb-dgpsa.ca",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/dhpp.hpfb-dgpsa.ca\/review-documents\/resource\/SBD00433",
                                    "title": "Summary Basis of Decision for Lutathera",
                                    "snippet": "The Summary Basis of Decision explains why the product was approved for sale in Canada. The document includes regulatory, safety, effectiveness and quality",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "dhpp.hpfb-dgpsa.ca"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "erc.bioscientifica.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/29\/2\/ERC-21-0248.xml",
                                    "title": "Prognostic stratification for patients with neuroendocrine ...",
                                    "snippet": "by L Chen · 2022 · Cited by 8 — The present study aimed to explore easily accessible markers in predicting the efficacy of 177 Lu-Dotatate treatment and to identify patients who would be less ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "erc.bioscientifica.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "arxiv.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/arxiv.org\/abs\/1710.05455",
                                    "title": "The Emergence of a Lanthanide-Rich Kilonova Following the Merger of Two Neutron Stars",
                                    "snippet": "",
                                    "ref_id": null,
                                    "pub_date": 1508173072,
                                    "attribution": "arxiv.org"
                                }
                            ]
                        }
                    ],
                    "debug_sonic_thread_id": "thread_68d25770c530832f9372e5538af23fa6",
                    "search_turns_count": 2,
                    "search_source": "composer_auto",
                    "client_reported_search_source": "composer_auto",
                    "request_id": "98389a1bc93dea37-FCO",
                    "message_type": "next",
                    "model_slug": "gpt-5",
                    "default_model_slug": "gpt-5",
                    "parent_id": "47f2cc20-159f-47f8-881d-91c5c11c8c2d",
                    "timestamp_": "absolute"
                },
                "recipient": "all",
                "channel": null
            },
            "parent": "47f2cc20-159f-47f8-881d-91c5c11c8c2d",
            "children": [
                "4a595c40-a55e-4649-ab12-15a1a6f8d2f4"
            ]
        },
        "4a595c40-a55e-4649-ab12-15a1a6f8d2f4": {
            "id": "4a595c40-a55e-4649-ab12-15a1a6f8d2f4",
            "message": {
                "id": "4a595c40-a55e-4649-ab12-15a1a6f8d2f4",
                "author": {
                    "role": "tool",
                    "name": "web.run",
                    "metadata": {
                        "sonicberry_model_id": "current_sonicberry_paid",
                        "real_author": "tool:web",
                        "source": "sonic_tool"
                    }
                },
                "create_time": 1758615413.6934216,
                "update_time": null,
                "content": {
                    "content_type": "text",
                    "parts": [
                        ""
                    ]
                },
                "status": "finished_successfully",
                "end_turn": false,
                "weight": 1,
                "metadata": {
                    "search_model_queries": {
                        "type": "search_model_queries",
                        "queries": [
                            "177Lu-DOTATATE Expert Rev Gastroenterol Hepatol 2019 Das acknowledgments grant award",
                            "award funding in that paper Expert Rev Gastroenterol Hepatol 2019 Satya Das grant award"
                        ]
                    },
                    "search_turns_count": 3,
                    "search_source": "composer_auto",
                    "client_reported_search_source": "composer_auto",
                    "request_id": "98389a1bc93dea37-FCO",
                    "message_type": "next",
                    "model_slug": "gpt-5",
                    "default_model_slug": "gpt-5",
                    "parent_id": "03af69e9-b855-4e55-a869-250018f3e359",
                    "timestamp_": "absolute"
                },
                "recipient": "all",
                "channel": null
            },
            "parent": "03af69e9-b855-4e55-a869-250018f3e359",
            "children": [
                "bddddee5-4ef5-4099-8d39-035866a813bb"
            ]
        },
        "bddddee5-4ef5-4099-8d39-035866a813bb": {
            "id": "bddddee5-4ef5-4099-8d39-035866a813bb",
            "message": {
                "id": "bddddee5-4ef5-4099-8d39-035866a813bb",
                "author": {
                    "role": "tool",
                    "name": "web.run",
                    "metadata": {
                        "sonicberry_model_id": "current_sonicberry_paid",
                        "real_author": "tool:web",
                        "source": "sonic_tool"
                    }
                },
                "create_time": 1758615413.6864276,
                "update_time": null,
                "content": {
                    "content_type": "text",
                    "parts": [
                        ""
                    ]
                },
                "status": "finished_successfully",
                "end_turn": false,
                "weight": 1,
                "metadata": {
                    "search_result_groups": [
                        {
                            "type": "search_result_group",
                            "domain": "pmc.ncbi.nlm.nih.gov",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/",
                                    "title": "177Lu-DOTATATE for the treatment ...",
                                    "snippet": "by S Das · 2019 · Cited by 140 — Expert Opinion: 177Lu-DOTATATE represents a unique addition to the treatment armamentarium for GEP NETs because of its potential to elicit tumor cytoreduction, ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "pmc.ncbi.nlm.nih.gov"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "mdpi-res.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/mdpi-res.com\/bookfiles\/book\/9352\/10th_Anniversary_of_BiomedicinesTranslational_Laboratory_and_Experimental_Medicine_for_the_Sake_of_Neurological_Diseases_and_Mental_Illnesses.pdf?v=1734142046",
                                    "title": "10th Anniversary of Biomedicines",
                                    "snippet": "... funding acquisition, M.T. and L.V. All authors have read and agreed to the published version of the manuscript. Funding: This work was supported by the ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "mdpi-res.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "pubmed.ncbi.nlm.nih.gov",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/pubmed.ncbi.nlm.nih.gov\/31652074\/",
                                    "title": "177Lu-DOTATATE for the treatment of ...",
                                    "snippet": "by S Das · 2019 · Cited by 140 — Expert Opinion: 177Lu-DOTATATE represents a unique addition to the treatment armamentarium for GEP NETs because of its potential to elicit tumor cytoreduction, ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "pubmed.ncbi.nlm.nih.gov"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "dspace.cuni.cz",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/dspace.cuni.cz\/bitstream\/handle\/20.500.11956\/201310\/140132458.pdf?isAllowed=y&sequence=1",
                                    "title": "CHARLES UNIVERSITY DOCTORAL THESIS",
                                    "snippet": "[162] K. S., P. D.S., Expert Rev. Gastroenterol. Hepatol. 2010, 4, 409–416. [163] J. G. Bartlett, N. Moon, T. W. Chang, N. Taylor, A. B. Onderdonk ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "dspace.cuni.cz"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "ajronline.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/ajronline.org\/doi\/10.2214\/AJR.19.21123",
                                    "title": "Therapy With 177 Lu-DOTATATE: Clinical Implementation and ...",
                                    "snippet": "by AT Kendi · 2019 · Cited by 64 — According to this assessment report, 177Lu-DOTATATE produced the largest health benefits of all treatment strategies investigated for gastrointestinal (midgut) ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "ajronline.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "lib.zu.edu.pk",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/lib.zu.edu.pk\/ebookdata\/Infectious%20Diseases\/Human%20Viruses_%20Diseases%2C%20Treatments%20and%20Vaccines_%20The%20New%20Insights-by%20Shamim%20I.%20Ahmad.pdf",
                                    "title": "Human Viruses: Diseases, Treatments and Vaccines",
                                    "snippet": "... 2019. The whole world is now experiencing very high numbers of infections and deaths. Turmoil includes economic damage due to a large number of factories ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "lib.zu.edu.pk"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "www.researchgate.net",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.researchgate.net\/publication\/336814696_177_Lu-DOTATATE_for_the_treatment_of_gastroenteropancreatic_neuroendocrine_tumors",
                                    "title": "(PDF) 177 Lu-DOTATATE for the treatment of ...",
                                    "snippet": "Oct 30, 2019 — Expert Opinion: ¹⁷⁷Lu-DOTATATE represents a unique addition to the treatment armamentarium for GEP NETs because of its potential to elicit tumor ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.researchgate.net"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.researchgate.net\/profile\/Rashid-Mir\/publication\/346097928_Stem_Cells_in_the_Treatment_of_Diabetic_Foot_Ulcers\/links\/60316f954585158939bbbf71\/Stem-Cells-in-the-Treatment-of-Diabetic-Foot-Ulcers.pdf",
                                    "title": "Stem-Cells-in-the-Treatment-of-Diabetic-Foot-Ulcers.pdf",
                                    "snippet": "... Award by. Diabetes India 2019. Abida Malik is a former Professor and Chairperson of the Department of. Microbiology, and the former Dean of the Faculty of ...",
                                    "ref_id": null,
                                    "pub_date": 1603988142,
                                    "attribution": "www.researchgate.net"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "www.esmo.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.esmo.org\/oncology-news\/177lu-dotatate-shows-promising-efficacy-in-the-treatment-of-patients-with-progressive-metastatic-pheochromocytomas-and-paragangliomas",
                                    "title": "177Lu-DOTATATE Shows Promising Efficacy in the ...",
                                    "snippet": "Sep 2, 2025 — In a phase II study, 177Lu-DOTATATE was generally well tolerated and showed promising efficacy in the treatment of patients with progressive ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.esmo.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "www.mdpi.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.mdpi.com\/1424-8247\/15\/9\/1085",
                                    "title": "Comparison of the Anti-Tumour Activity of the Somatostatin ...",
                                    "snippet": "by P Plas · 2022 · Cited by 5 — Das, S.; Al-Toubah, T.; El-Haddad, G.; Strosberg, J. 177Lu-DOTA-TATE for the treatment of gastroenteropancreatic neuroendocrine tumours. Expert Rev.",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.mdpi.com"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.mdpi.com\/2072-6694\/13\/5\/962",
                                    "title": "Peptide Receptor Radionuclide Therapy (PRRT) with 177 ...",
                                    "snippet": "by U Jahn · 2021 · Cited by 55 — 177Lu-DOTATATE peptide receptor radionuclide therapy: Dose response in small intestinal neuroendocrine tumors. Neuroendocrinology 2019, 110, 662–670.",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.mdpi.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "www.youtube.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.youtube.com\/watch?v=ivlUC35F03g",
                                    "title": "Evaluating 177Lu-DOTATATE in PPGLs: Insights from a ...",
                                    "snippet": "Frank I Lin, MD, of the National Institutes of Health, provides an in-depth overview of his team's study that evaluated the use of 177Lu- ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "www.youtube.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "jbpe.sums.ac.ir",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/jbpe.sums.ac.ir\/article_48455.html",
                                    "title": "Radiomics Analysis for Clinical Decision Support in 177Lu ...",
                                    "snippet": "by B Behmanesh · 2024 · Cited by 2 — Experimental findings show that using 177Lu-DOTATATE therapy for advanced, metastatic gastrointestinal ... (Grant No 24938). Authors' Contribution. MR ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "jbpe.sums.ac.ir"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "pure.eur.nl",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/pure.eur.nl\/files\/100695585\/thesismaryanadigitalv1_-_650812975fd74.pdf",
                                    "title": "final dissertation Handula, Maryana",
                                    "snippet": "by M Handula · 2023 — 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors. Expert Rev Gastroenterol Hepatol 2019;13:1023−1031. 57 ...",
                                    "ref_id": null,
                                    "pub_date": null,
                                    "attribution": "pure.eur.nl"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "en.wikipedia.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/en.wikipedia.org\/wiki\/Lutetium_%28177Lu%29_oxodotreotide",
                                    "title": "Lutetium (177Lu) oxodotreotide",
                                    "snippet": "",
                                    "ref_id": null,
                                    "pub_date": 1748553841,
                                    "attribution": "en.wikipedia.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "arxiv.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/arxiv.org\/abs\/1910.09199",
                                    "title": "Identification of the Blood Perfusion Rate for Laser-Induced Thermotherapy in the Liver",
                                    "snippet": "",
                                    "ref_id": null,
                                    "pub_date": 1571646183,
                                    "attribution": "arxiv.org"
                                }
                            ]
                        }
                    ],
                    "debug_sonic_thread_id": "thread_68d25770c530832f9372e5538af23fa6",
                    "search_turns_count": 3,
                    "search_source": "composer_auto",
                    "client_reported_search_source": "composer_auto",
                    "request_id": "98389a1bc93dea37-FCO",
                    "message_type": "next",
                    "model_slug": "gpt-5",
                    "default_model_slug": "gpt-5",
                    "parent_id": "4a595c40-a55e-4649-ab12-15a1a6f8d2f4",
                    "timestamp_": "absolute"
                },
                "recipient": "all",
                "channel": null
            },
            "parent": "4a595c40-a55e-4649-ab12-15a1a6f8d2f4",
            "children": [
                "56434399-aeb8-4427-a392-73120aef0a18"
            ]
        },
        "56434399-aeb8-4427-a392-73120aef0a18": {
            "id": "56434399-aeb8-4427-a392-73120aef0a18",
            "message": {
                "id": "56434399-aeb8-4427-a392-73120aef0a18",
                "author": {
                    "role": "assistant",
                    "name": null,
                    "metadata": {
                        "sonicberry_model_id": "current_sonicberry_paid",
                        "real_author": "tool:web",
                        "source": "sonic_tool"
                    }
                },
                "create_time": 1758615414.830352,
                "update_time": null,
                "content": {
                    "content_type": "text",
                    "parts": [
                        "In the paper *“¹⁷⁷Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors”* by Satya Das et al. (2019) citeturn1search2turn1search0turn2search0 the award listed in the acknowledgments section is the **Vanderbilt-Ingram Cancer Center’s Physician Scientist Development Award** citeturn2search0"
                    ]
                },
                "status": "finished_successfully",
                "end_turn": true,
                "weight": 1,
                "metadata": {
                    "content_references": [
                        {
                            "matched_text": "citeturn1search2turn1search0turn2search0",
                            "start_idx": 125,
                            "end_idx": 170,
                            "safe_urls": [
                                "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/?utm_source=chatgpt.com",
                                "https:\/\/pubmed.ncbi.nlm.nih.gov\/31652074\/?utm_source=chatgpt.com"
                            ],
                            "refs": [],
                            "alt": "([PubMed](https:\/\/pubmed.ncbi.nlm.nih.gov\/31652074\/?utm_source=chatgpt.com))",
                            "prompt_text": null,
                            "type": "grouped_webpages",
                            "items": [
                                {
                                    "title": "177Lu-DOTATATE for the treatment of ...",
                                    "url": "https:\/\/pubmed.ncbi.nlm.nih.gov\/31652074\/?utm_source=chatgpt.com",
                                    "pub_date": null,
                                    "snippet": "by S Das · 2019 · Cited by 140 — 177 Lu-DOTATATE is a type of peptide receptor radionuclide therapy that garnered FDA approval in January 2018 for the treatment of somatostatin receptor- ...",
                                    "attribution_segments": null,
                                    "supporting_websites": [
                                        {
                                            "title": "177Lu-DOTATATE for the treatment ...",
                                            "url": "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/?utm_source=chatgpt.com",
                                            "pub_date": null,
                                            "snippet": "by S Das · 2019 · Cited by 140 — 177 Lu-DOTATATE is a type of peptide receptor radionuclide therapy that garnered FDA approval in January 2018 for the treatment of somatostatin receptor- ...",
                                            "attribution": "PMC"
                                        },
                                        {
                                            "title": "177Lu-DOTATATE for the treatment ...",
                                            "url": "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/?utm_source=chatgpt.com",
                                            "pub_date": null,
                                            "snippet": "by S Das · 2019 · Cited by 140 — Expert Opinion: 177Lu-DOTATATE represents a unique addition to the treatment armamentarium for GEP NETs because of its potential to elicit tumor cytoreduction, ...",
                                            "attribution": "PMC"
                                        }
                                    ],
                                    "refs": [
                                        {
                                            "turn_index": 1,
                                            "ref_type": "search",
                                            "ref_index": 2
                                        },
                                        {
                                            "turn_index": 1,
                                            "ref_type": "search",
                                            "ref_index": 0
                                        },
                                        {
                                            "turn_index": 2,
                                            "ref_type": "search",
                                            "ref_index": 0
                                        }
                                    ],
                                    "hue": null,
                                    "attributions": null,
                                    "attribution": "PubMed"
                                }
                            ],
                            "fallback_items": null,
                            "status": "done",
                            "error": null,
                            "style": null
                        },
                        {
                            "matched_text": "citeturn2search0",
                            "start_idx": 302,
                            "end_idx": 321,
                            "safe_urls": [
                                "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/?utm_source=chatgpt.com"
                            ],
                            "refs": [],
                            "alt": "([PMC](https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/?utm_source=chatgpt.com))",
                            "prompt_text": null,
                            "type": "grouped_webpages",
                            "items": [
                                {
                                    "title": "177Lu-DOTATATE for the treatment ...",
                                    "url": "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/?utm_source=chatgpt.com",
                                    "pub_date": null,
                                    "snippet": "by S Das · 2019 · Cited by 140 — Expert Opinion: 177Lu-DOTATATE represents a unique addition to the treatment armamentarium for GEP NETs because of its potential to elicit tumor cytoreduction, ...",
                                    "attribution_segments": null,
                                    "supporting_websites": [],
                                    "refs": [
                                        {
                                            "turn_index": 2,
                                            "ref_type": "search",
                                            "ref_index": 0
                                        }
                                    ],
                                    "hue": null,
                                    "attributions": null,
                                    "attribution": "PMC"
                                }
                            ],
                            "fallback_items": null,
                            "status": "done",
                            "error": null,
                            "style": null
                        },
                        {
                            "matched_text": " ",
                            "start_idx": 321,
                            "end_idx": 321,
                            "safe_urls": [],
                            "refs": [],
                            "alt": "",
                            "prompt_text": null,
                            "type": "sources_footnote",
                            "sources": [
                                {
                                    "title": "177Lu-DOTATATE for the treatment of ...",
                                    "url": "https:\/\/pubmed.ncbi.nlm.nih.gov\/31652074\/?utm_source=chatgpt.com",
                                    "attribution": "PubMed"
                                },
                                {
                                    "title": "177Lu-DOTATATE for the treatment ...",
                                    "url": "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/?utm_source=chatgpt.com",
                                    "attribution": "PMC"
                                }
                            ],
                            "has_images": false
                        }
                    ],
                    "safe_urls": [
                        "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/?utm_source=chatgpt.com",
                        "https:\/\/pubmed.ncbi.nlm.nih.gov\/31652074\/?utm_source=chatgpt.com",
                        "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/?utm_source=chatgpt.com"
                    ],
                    "search_result_groups": [
                        {
                            "type": "search_result_group",
                            "domain": "oncpracticemanagement.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/oncpracticemanagement.com\/special-issues\/2019-fourth-annual-oncology-guide-to-new-fda-approvals\/lutathera-lutetium-lu-177-dotatate-first-radioactive-drug-approved-for-gastroenteropancreatic-neuroendocrine-tumors?utm_source=chatgpt.com",
                                    "title": "Lutathera (Lutetium Lu 177 Dotatate) First Radioactive ...",
                                    "snippet": "by LA Raedler · Cited by 2 — Lutathera is a radiolabeled somatostatin analog, the first radiopharmaceutical and peptide receptor radionuclide therapy (PRRT) approved for GEP-NETs.",
                                    "ref_id": {
                                        "turn_index": 0,
                                        "ref_type": "search",
                                        "ref_index": 1
                                    },
                                    "pub_date": null,
                                    "attribution": "oncpracticemanagement.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "mdpi-res.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/mdpi-res.com\/bookfiles\/book\/9352\/10th_Anniversary_of_BiomedicinesTranslational_Laboratory_and_Experimental_Medicine_for_the_Sake_of_Neurological_Diseases_and_Mental_Illnesses.pdf?v=1734142046&utm_source=chatgpt.com",
                                    "title": "10th Anniversary of Biomedicines",
                                    "snippet": "... funding acquisition, M.T. and L.V. All authors have read and agreed to the published version of the manuscript. Funding: This work was supported by the ...",
                                    "ref_id": {
                                        "turn_index": 2,
                                        "ref_type": "search",
                                        "ref_index": 1
                                    },
                                    "pub_date": null,
                                    "attribution": "mdpi-res.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "frontiersin.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.frontiersin.org\/journals\/nuclear-medicine\/articles\/10.3389\/fnume.2025.1655419\/full?utm_source=chatgpt.com",
                                    "title": "Targeted radionuclide therapy and diagnostic imaging of ...",
                                    "snippet": "by KN Haugh — The most recent FDA-approved radiopharmaceutical for NET imaging is [64Cu]Cu-DOTA-TATE (Detectnet), which was FDA-approved in 2020 (12). Several clinical trials ...",
                                    "ref_id": {
                                        "turn_index": 0,
                                        "ref_type": "search",
                                        "ref_index": 2
                                    },
                                    "pub_date": null,
                                    "attribution": "frontiersin.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "nih.gov",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11876735\/?utm_source=chatgpt.com",
                                    "title": "Results from a Substudy of the Phase III NETTER-1 Trial",
                                    "snippet": "by L Bodei · 2025 · Cited by 6 — Herein, we describe a NETTER-1 substudy that evaluated dosimetry (normal organs, whole body, and scintigraphically selected tumors) in patients ...",
                                    "ref_id": {
                                        "turn_index": 0,
                                        "ref_type": "search",
                                        "ref_index": 3
                                    },
                                    "pub_date": null,
                                    "attribution": "nih.gov"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11002837\/?utm_source=chatgpt.com",
                                    "title": "Current clinical application of lutetium‑177 in solid tumors ...",
                                    "snippet": "by T Niu · 2024 · Cited by 9 — In March, 2022, the U.S. Food and Drug Administration (FDA) approved the administration of 177Lu-PSMA-617 for the treatment of adult patients with mCRPC, making ...",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 12
                                    },
                                    "pub_date": null,
                                    "attribution": "nih.gov"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "snmjournals.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/jnm.snmjournals.org\/content\/66\/7\/1075?utm_source=chatgpt.com",
                                    "title": "Cost-Effectiveness of [177Lu]Lu-DOTATATE for the Treatment ...",
                                    "snippet": "by A Holzgreve · 2025 · Cited by 1 — [ 177 Lu]Lu-DOTATATE is cost-effective as a first-line treatment for patients with grade 2 or 3, well-differentiated, advanced gastroenteropancreatic ...",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 3
                                    },
                                    "pub_date": null,
                                    "attribution": "snmjournals.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/jnm.snmjournals.org\/content\/65\/5\/746?utm_source=chatgpt.com",
                                    "title": "Effectiveness and Safety of Retreatment with 177 Lu ...",
                                    "snippet": "by ES Delpassand · 2024 · Cited by 3 — Retreatment with 177 Lu-DOTATATE after progression appeared to be well tolerated and offered disease control in patients with progressive NETs after initial ...",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 7
                                    },
                                    "pub_date": null,
                                    "attribution": "snmjournals.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/jnm.snmjournals.org\/content\/61\/7\/939?utm_source=chatgpt.com",
                                    "title": "Unacceptable Denials | Journal of Nuclear Medicine",
                                    "snippet": "by J Czernin · 2020 · Cited by 1 — It also fails to acknowledge Centers for Medicare and Medicaid Services coverage of Lutathera. The denial letter indicates that Health Net ...",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 8
                                    },
                                    "pub_date": null,
                                    "attribution": "snmjournals.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/jnm.snmjournals.org\/content\/66\/3\/449?utm_source=chatgpt.com",
                                    "title": "Dosimetry of [177Lu]Lu-DOTATATE in Patients with Advanced ...",
                                    "snippet": "by L Bodei · 2025 · Cited by 7 — ACKNOWLEDGMENTS. Under the direction of the authors, Jo Chapman, PhD, from Aspire Scientific Ltd., Bollington, U.K., provided medical writing ...",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 18
                                    },
                                    "pub_date": null,
                                    "attribution": "snmjournals.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "cuni.cz",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/dspace.cuni.cz\/bitstream\/handle\/20.500.11956\/201310\/140132458.pdf?isAllowed=y&sequence=1&utm_source=chatgpt.com",
                                    "title": "CHARLES UNIVERSITY DOCTORAL THESIS",
                                    "snippet": "[162] K. S., P. D.S., Expert Rev. Gastroenterol. Hepatol. 2010, 4, 409–416. [163] J. G. Bartlett, N. Moon, T. W. Chang, N. Taylor, A. B. Onderdonk ...",
                                    "ref_id": {
                                        "turn_index": 2,
                                        "ref_type": "search",
                                        "ref_index": 3
                                    },
                                    "pub_date": null,
                                    "attribution": "cuni.cz"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "mdpi.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.mdpi.com\/1424-8247\/12\/3\/114?utm_source=chatgpt.com",
                                    "title": "Lutathera®: The First FDA- and EMA-Approved ...",
                                    "snippet": "by U Hennrich · 2019 · Cited by 448 — As the first radiopharmaceutical for Peptide Receptor Radionuclide Therapy (PRRT), Lutathera® was approved by the EMA in 2017 and the FDA in 2018 for the ...",
                                    "ref_id": {
                                        "turn_index": 0,
                                        "ref_type": "search",
                                        "ref_index": 4
                                    },
                                    "pub_date": null,
                                    "attribution": "mdpi.com"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.mdpi.com\/2227-9059\/11\/4\/1024?utm_source=chatgpt.com",
                                    "title": "Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Adults with ...",
                                    "snippet": "by M Hertelendi · 2023 · Cited by 6 — Background: We have performed a systematic review to evaluate the efficacy and safety of [177Lu]Lu-DOTA-TATE, a radioligand therapy, ...",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 17
                                    },
                                    "pub_date": null,
                                    "attribution": "mdpi.com"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.mdpi.com\/1424-8247\/15\/9\/1085?utm_source=chatgpt.com",
                                    "title": "Comparison of the Anti-Tumour Activity of the Somatostatin ...",
                                    "snippet": "by P Plas · 2022 · Cited by 5 — Das, S.; Al-Toubah, T.; El-Haddad, G.; Strosberg, J. 177Lu-DOTA-TATE for the treatment of gastroenteropancreatic neuroendocrine tumours. Expert Rev.",
                                    "ref_id": {
                                        "turn_index": 2,
                                        "ref_type": "search",
                                        "ref_index": 9
                                    },
                                    "pub_date": null,
                                    "attribution": "mdpi.com"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.mdpi.com\/2072-6694\/13\/5\/962?utm_source=chatgpt.com",
                                    "title": "Peptide Receptor Radionuclide Therapy (PRRT) with 177 ...",
                                    "snippet": "by U Jahn · 2021 · Cited by 55 — 177Lu-DOTATATE peptide receptor radionuclide therapy: Dose response in small intestinal neuroendocrine tumors. Neuroendocrinology 2019, 110, 662–670.",
                                    "ref_id": {
                                        "turn_index": 2,
                                        "ref_type": "search",
                                        "ref_index": 11
                                    },
                                    "pub_date": null,
                                    "attribution": "mdpi.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "aacrjournals.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/aacrjournals.org\/clincancerres\/article\/25\/23\/6939\/82129\/Phase-I-Trial-of-Well-Differentiated?utm_source=chatgpt.com",
                                    "title": "Phase I Trial of Well-Differentiated Neuroendocrine Tumors ...",
                                    "snippet": "We performed a phase I study to evaluate the safety and efficacy of SSTR2 antagonist 177 Lu-satoreotide tetraxetan.",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 4
                                    },
                                    "pub_date": null,
                                    "attribution": "aacrjournals.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/aacrjournals.org\/mct\/article\/22\/9\/1052\/728674\/Upregulation-of-Somatostatin-Receptor-Type-2?utm_source=chatgpt.com",
                                    "title": "Upregulation of Somatostatin Receptor Type 2 Improves 177 ...",
                                    "snippet": "Our studies demonstrate significantly higher tumor uptake of SSTR2-targeted 177 Lu-DOTATATE in animals pretreated with HDACis compared with controls.",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 13
                                    },
                                    "pub_date": null,
                                    "attribution": "aacrjournals.org"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/aacrjournals.org\/mct\/article\/18\/5\/1012\/274167\/Preclinical-Investigation-of-212Pb-DOTAMTATE-for?utm_source=chatgpt.com",
                                    "title": "Preclinical Investigation of 212 Pb-DOTAMTATE for Peptide ...",
                                    "snippet": "Our study describes the use of 212 Pb-DOTAMTATE, the octreotate analogue, in combination with 212 Pb, the parent of an alpha emitter.",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 16
                                    },
                                    "pub_date": null,
                                    "attribution": "aacrjournals.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "nature.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.nature.com\/articles\/s41573-020-0073-9?utm_source=chatgpt.com",
                                    "title": "Radiopharmaceutical therapy in cancer: clinical advances ...",
                                    "snippet": "by G Sgouros · 2020 · Cited by 912 — Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach to treating many types of cancer.",
                                    "ref_id": {
                                        "turn_index": 0,
                                        "ref_type": "search",
                                        "ref_index": 5
                                    },
                                    "pub_date": null,
                                    "attribution": "nature.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "sciencedirect.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2949819825000159?utm_source=chatgpt.com",
                                    "title": "The South Australian 177Lu-DOTATATE peptide receptor ...",
                                    "snippet": "by LM Altus · 2025 — We report on 189 patients who received 177 Lu-DOTATATE at a single South Australian centre over 11 years. Median overall survival was 48.4 months.",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 5
                                    },
                                    "pub_date": null,
                                    "attribution": "sciencedirect.com"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0969805121000032?utm_source=chatgpt.com",
                                    "title": "Direct labeling of a somatostatin receptor antagonist via ...",
                                    "snippet": "by J Wang · 2021 · Cited by 6 — Acknowledgments. This work was supported by a University of Missouri Research Council award [Hennkens, URC 12-056] for funding and by the Institution ...",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 6
                                    },
                                    "pub_date": null,
                                    "attribution": "sciencedirect.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "zu.edu.pk",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/lib.zu.edu.pk\/ebookdata\/Infectious%20Diseases\/Human%20Viruses_%20Diseases%2C%20Treatments%20and%20Vaccines_%20The%20New%20Insights-by%20Shamim%20I.%20Ahmad.pdf?utm_source=chatgpt.com",
                                    "title": "Human Viruses: Diseases, Treatments and Vaccines",
                                    "snippet": "... 2019. The whole world is now experiencing very high numbers of infections and deaths. Turmoil includes economic damage due to a large number of factories ...",
                                    "ref_id": {
                                        "turn_index": 2,
                                        "ref_type": "search",
                                        "ref_index": 5
                                    },
                                    "pub_date": null,
                                    "attribution": "zu.edu.pk"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "cms.gov",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.cms.gov\/medicare-coverage-database\/view\/lcd.aspx?lcdid=37851&ver=13&utm_source=chatgpt.com",
                                    "title": "Biomarker Testing for Neuroendocrine Tumors\/Neoplasms",
                                    "snippet": "This document is about biomarker testing for neuroendocrine tumors, but the real-time PCR test is not covered as it is not medically necessary.",
                                    "ref_id": {
                                        "turn_index": 0,
                                        "ref_type": "search",
                                        "ref_index": 6
                                    },
                                    "pub_date": null,
                                    "attribution": "cms.gov"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "fda.gov",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.fda.gov\/media\/164194\/download?utm_source=chatgpt.com",
                                    "title": "FDA Food Code 2022: Full Document",
                                    "snippet": "The Food Code is a model for safeguarding public health and ensuring food is unadulterated and honestly presented when offered to the consumer. It represents ...",
                                    "ref_id": {
                                        "turn_index": 0,
                                        "ref_type": "search",
                                        "ref_index": 7
                                    },
                                    "pub_date": null,
                                    "attribution": "fda.gov"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "researchgate.net",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.researchgate.net\/publication\/336814696_177_Lu-DOTATATE_for_the_treatment_of_gastroenteropancreatic_neuroendocrine_tumors?utm_source=chatgpt.com",
                                    "title": "(PDF) 177 Lu-DOTATATE for the treatment of ...",
                                    "snippet": "Oct 30, 2019 — Abstract and Figures ; 177. Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine. tumors ; Satya Das. a. , Taymeyah Al-Toubah ; b.",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 9
                                    },
                                    "pub_date": null,
                                    "attribution": "researchgate.net"
                                },
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.researchgate.net\/profile\/Rashid-Mir\/publication\/346097928_Stem_Cells_in_the_Treatment_of_Diabetic_Foot_Ulcers\/links\/60316f954585158939bbbf71\/Stem-Cells-in-the-Treatment-of-Diabetic-Foot-Ulcers.pdf?utm_source=chatgpt.com",
                                    "title": "Stem-Cells-in-the-Treatment-of-Diabetic-Foot-Ulcers.pdf",
                                    "snippet": "... Award by. Diabetes India 2019. Abida Malik is a former Professor and Chairperson of the Department of. Microbiology, and the former Dean of the Faculty of ...",
                                    "ref_id": {
                                        "turn_index": 2,
                                        "ref_type": "search",
                                        "ref_index": 7
                                    },
                                    "pub_date": null,
                                    "attribution": "researchgate.net"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "af.mil",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/static.e-publishing.af.mil\/production\/1\/saf_ig\/publication\/dafi90-302\/dafi90-302.pdf?utm_source=chatgpt.com",
                                    "title": "dafi90-302.pdf - Air Force - AF.mil",
                                    "snippet": "Mar 15, 2023 — This instruction provides policy for inspections involving Air Force and Space Force organizations, processes, programs, and procedures. It ...",
                                    "ref_id": {
                                        "turn_index": 0,
                                        "ref_type": "search",
                                        "ref_index": 8
                                    },
                                    "pub_date": null,
                                    "attribution": "af.mil"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "esmo.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.esmo.org\/oncology-news\/177lu-dotatate-shows-promising-efficacy-in-the-treatment-of-patients-with-progressive-metastatic-pheochromocytomas-and-paragangliomas?utm_source=chatgpt.com",
                                    "title": "177Lu-DOTATATE Shows Promising Efficacy in the ...",
                                    "snippet": "Sep 2, 2025 — In a phase II study, 177Lu-DOTATATE was generally well tolerated and showed promising efficacy in the treatment of patients with progressive ...",
                                    "ref_id": {
                                        "turn_index": 2,
                                        "ref_type": "search",
                                        "ref_index": 8
                                    },
                                    "pub_date": null,
                                    "attribution": "esmo.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "texas.gov",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/cprit.texas.gov\/media\/3347\/oc_board_packet_05152024.pdf?utm_source=chatgpt.com",
                                    "title": "Oversight Committee Meeting",
                                    "snippet": "May 15, 2024 — Ken Smith will provide an update on the Product Development Research Program and present the PIC's product development award recommendations.",
                                    "ref_id": {
                                        "turn_index": 0,
                                        "ref_type": "search",
                                        "ref_index": 9
                                    },
                                    "pub_date": null,
                                    "attribution": "texas.gov"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "ajronline.org",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/ajronline.org\/doi\/10.2214\/AJR.19.21123?utm_source=chatgpt.com",
                                    "title": "Therapy With 177 Lu-DOTATATE: Clinical Implementation and ...",
                                    "snippet": "by AT Kendi · 2019 · Cited by 64 — The purpose of this article is to enhance knowledge of the clinical implementation of peptide receptor radionuclide therapy (PRRT) and its impact on care of ...",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 10
                                    },
                                    "pub_date": null,
                                    "attribution": "ajronline.org"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "youtube.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/www.youtube.com\/watch?v=ivlUC35F03g&utm_source=chatgpt.com",
                                    "title": "Evaluating 177Lu-DOTATATE in PPGLs: Insights from a ...",
                                    "snippet": "Frank I Lin, MD, of the National Institutes of Health, provides an in-depth overview of his team's study that evaluated the use of 177Lu- ...",
                                    "ref_id": {
                                        "turn_index": 2,
                                        "ref_type": "search",
                                        "ref_index": 10
                                    },
                                    "pub_date": null,
                                    "attribution": "youtube.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "springer.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/link.springer.com\/article\/10.1007\/s00259-022-05771-3?utm_source=chatgpt.com",
                                    "title": "Efficacy and safety of 177 Lu‑DOTATATE in patients with ...",
                                    "snippet": "by D Clement · 2022 · Cited by 18 — Acknowledgements. The authors thank Ivan De Backer, PhD, and NexGen Healthcare Communications for medical writing support, funded by Advanced ...",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 11
                                    },
                                    "pub_date": null,
                                    "attribution": "springer.com"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "sums.ac.ir",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/jbpe.sums.ac.ir\/article_48455.html?utm_source=chatgpt.com",
                                    "title": "Radiomics Analysis for Clinical Decision Support in 177Lu ...",
                                    "snippet": "by B Behmanesh · 2024 · Cited by 2 — Experimental findings show that using 177Lu-DOTATATE therapy for advanced, metastatic gastrointestinal ... (Grant No 24938). Authors' Contribution. MR ...",
                                    "ref_id": {
                                        "turn_index": 2,
                                        "ref_type": "search",
                                        "ref_index": 12
                                    },
                                    "pub_date": null,
                                    "attribution": "sums.ac.ir"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "eur.nl",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/pure.eur.nl\/files\/100695585\/thesismaryanadigitalv1_-_650812975fd74.pdf?utm_source=chatgpt.com",
                                    "title": "final dissertation Handula, Maryana",
                                    "snippet": "by M Handula · 2023 — 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors. Expert Rev Gastroenterol Hepatol 2019;13:1023−1031. 57 ...",
                                    "ref_id": {
                                        "turn_index": 2,
                                        "ref_type": "search",
                                        "ref_index": 13
                                    },
                                    "pub_date": null,
                                    "attribution": "eur.nl"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "hpfb-dgpsa.ca",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/dhpp.hpfb-dgpsa.ca\/review-documents\/resource\/SBD00433?utm_source=chatgpt.com",
                                    "title": "Summary Basis of Decision for Lutathera",
                                    "snippet": "The Summary Basis of Decision explains why the product was approved for sale in Canada. The document includes regulatory, safety, effectiveness and quality",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 14
                                    },
                                    "pub_date": null,
                                    "attribution": "hpfb-dgpsa.ca"
                                }
                            ]
                        },
                        {
                            "type": "search_result_group",
                            "domain": "bioscientifica.com",
                            "entries": [
                                {
                                    "type": "search_result",
                                    "url": "https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/29\/2\/ERC-21-0248.xml?utm_source=chatgpt.com",
                                    "title": "Prognostic stratification for patients with neuroendocrine ...",
                                    "snippet": "by L Chen · 2022 · Cited by 8 — The present study aimed to explore easily accessible markers in predicting the efficacy of 177 Lu-Dotatate treatment and to identify patients who would be less ...",
                                    "ref_id": {
                                        "turn_index": 1,
                                        "ref_type": "search",
                                        "ref_index": 15
                                    },
                                    "pub_date": null,
                                    "attribution": "bioscientifica.com"
                                }
                            ]
                        }
                    ],
                    "citations": [],
                    "search_turns_count": 3,
                    "search_source": "composer_auto",
                    "client_reported_search_source": "composer_auto",
                    "request_id": "98389a1bc93dea37-FCO",
                    "message_type": "next",
                    "model_slug": "gpt-5",
                    "default_model_slug": "gpt-5",
                    "parent_id": "bddddee5-4ef5-4099-8d39-035866a813bb",
                    "timestamp_": "absolute",
                    "model_switcher_deny": []
                },
                "recipient": "all",
                "channel": null
            },
            "parent": "bddddee5-4ef5-4099-8d39-035866a813bb",
            "children": []
        }
    },
    "moderation_results": [],
    "current_node": "56434399-aeb8-4427-a392-73120aef0a18",
    "plugin_ids": null,
    "conversation_id": "68d2576e-4b9c-8326-aec8-17964e5aabc5",
    "conversation_template_id": null,
    "gizmo_id": null,
    "gizmo_type": null,
    "is_archived": false,
    "is_starred": null,
    "safe_urls": [
        "https:\/\/github.com\/xinjin95\/app-third-party-library",
        "https:\/\/pubmed.ncbi.nlm.nih.gov\/31652074\/?utm_source=chatgpt.com",
        "https:\/\/github.com\/MicheleDaniele\/ReterRefresh.git",
        "https:\/\/github.com\/MicheleDaniele\/reterRefreshBackend.git",
        "https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7227421\/?utm_source=chatgpt.com"
    ],
    "blocked_urls": [],
    "default_model_slug": "gpt-5",
    "conversation_origin": null,
    "voice": null,
    "async_status": null,
    "disabled_tool_ids": [],
    "is_do_not_remember": false,
    "memory_scope": "global_enabled",
    "sugar_item_id": null,
    "sugar_item_visible": false,
    "is_study_mode": false,
    "owner": null
}